Siren, L.L.C. Longboard Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
A detailed history of Siren, L.L.C. transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 903,227 shares of LBPH stock, worth $54 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
903,227Holding current value
$54 Million% of portfolio
1.5%Shares
1 transactions
Others Institutions Holding LBPH
# of Institutions
121Shares Held
36.2MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$197 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.15MShares$188 Million0.53% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$167 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$150 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $812M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...